LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Lima Corporate Installs Its 100, 000th Hip Stem
Large Joints and Extremities

Lima Corporate Installs Its 100, 000th Hip Stem

January 5, 2015 1 min read Premium comments

Advertisement

Lima Corporate Installs Its 100, 000th Hip Stem
Courtesy: Lima Corporate
Secondary

Lima Corporate, an Italian medical device company located in San Daniele del Friuli, Udine, reports that it has installed 100, 000 of its C2 Hip Stems since the product was launched. This puts the company on track to install more than 40, 000 implants of the entire Hip Femoral Prosthesis line by the end of 2014.

Professor Cremonese of the Ospedale di Cittadella, in Padua, Italy, designed the C2 Hip Stem which, according to the company, has since become an integral part of the Lima Corporate Total Hip Arthroplasty solutions. Officials report that the firm is strongly committed to internationalization. Lima Corporate has 14 foreign subsidiaries worldwide along with production facilities in Italy and the Republic of San Marino.

Professor Cremonese is Director of Orthopaedics and Traumatology at the Veneto Regional Center for the diagnosis and treatment of osteoarthritis of the hip. He has performed more than ten thousand orthopedic surgeries with particular focus on surgery of the shoulder and hip. Professor Cremonese is also a faculty member of the Italian Society of Arthroscopy.

“We expect demand to continue to accelerate next year, ” said Luigi Ferrari, Chief Executive Officer of Lima Corporate. “The C2 Hip Stem is implanted in more than 17 Countries worldwide, supported by over 14 years of clinical history and success remaining one of Lima’s most successful stems. The stem is designed to significantly improve the patient’s quality of life”.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy